Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NEW PRODUCTS
April 24, 2006
- Huma to Expand Clinical Trial Volunteer Recruitment Business
April 24, 2006
- Mr Iwasaki to Improve Labor-Management Relations via Dialogue: Pfizer Japan
April 17, 2006
- SEMINAR
April 17, 2006
- Kowa, Nikken's Integration Plan Accredited
April 17, 2006
- Sawai Expands Business with Wholesalers, Dispensing Pharmacies
April 17, 2006
- BUSINESS NEWS IN BRIEF
April 17, 2006
- GENERIC NEWS IN BRIEF
April 17, 2006
- Council to Collect Evidence on Pediatric Use of 5 Drugs
April 17, 2006
- Ordinance Issued on Designation of Vaccines as Orphan Drugs
April 17, 2006
- REGULATORY NEWS IN BRIEF
April 17, 2006
- BOOK
April 17, 2006
- EPS Establishes Subsidiary to Support Clin. Trials in Asia
April 17, 2006
- Seretide Lowers Mortality of COPD: GSK
April 17, 2006
- R&D NEWS IN BRIEF
April 17, 2006
- Pharmacists Want More Info. on Changes in Packaging, Formulation
April 17, 2006
- Sankyo Daiichi Aims for \100 Bil. Sales in CHC Business with Acquisition of Zepharma
April 17, 2006
- Boehringer Ingelheim to Remain Independent: Dr Banchi
April 17, 2006
- Major Drug Firms Offer Better Child-Rearing Leave than Law Requires
April 17, 2006
- Mochida Aims for Sales of \79 Bil. in New 3-Year Plan
April 17, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…